Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 73Observational 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1CNS 1

Conditions

Glioblastoma 12Astrocytoma 4Glioma 3Thrombocytopenia 1Oligodendroglioma 1Gliosarcoma 1Ependymoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Surveys and Questionnaires 2Psychiatric Rehabilitation 2Magnetic Resonance Spectroscopy 2Amplified Fragment Length Polymorphism Analysis 2fluarix 1Tetanus Toxoid 1Temozolomide 1Radiotherapy 1Quality of Life 1Proton Magnetic Resonance Spectroscopy 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Mental Status and Dementia Tests 1Influenza Vaccines 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Hepatitis A Vaccines 1FluLaval 1FluBlok 1Flow Cytometry 1Comparative Genomic Hybridization 1Climate Anxiety 1Anthropogenic Effects 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Oligodendroglioma × Temozolomide × Clear all
NCT00471653 2018-07-09

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Terminated
10 enrolled
CNSClassical hematologySarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Thrombocytopenia, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡